Stay updated on Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed Revision: v3.4.1 and the government funding-status notice.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice about government funding lapse and NIH operating status added; site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a 'Show glossary' option and new metadata lines 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the prior items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive changes to the study content or eligibility criteria are indicated.SummaryDifference0.0%

- Check63 days agoChange DetectedA Locations section listing participating sites by state (CT, DC, GA, IL, MA, NJ, NY, OH, PA, TX) was added, and the corresponding state-specific subsections (e.g., CT Locations) were removed. The revision updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check92 days agoChange DetectedThe Publications section now includes a note that publications are automatically filled from PubMed and may not all be about the study, and the revision tag shows Revision: v3.3.2. The previous PubMed description and Revision: v3.2.0 have been removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page.